Samsung Pharmaceutical Orders Recall of 5 Items Including Geramin Injection
[Asia Economy Reporter Choi Dae-yeol] Samsung Pharmaceutical announced on the 8th that it has decided to recall Geramin Injection, Moarex Injection, Combisin Injection, Combisin Injection 3g, and Combisin Injection 4.5g in accordance with the recall order issued by the Gyeongin Regional Food and Drug Administration. The sales of these products last year amounted to approximately 7.95 billion KRW.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
